We have shown previously that dendritic cells (DC) produce IL-12 upon interaction with CD4+ T cells. Here we ask how this IL-12 production is induced and regulated. Quantitative PCR. and in situ hybridization for IL-12 p40 and an ELISA specific for the p70 heterodimer were used to determine IL-12 production. We demonstrate that ligation of either CD40 or MHC class II molecules independently trigger IL-12 production in DC, and that IL-12 production is downregulated by IL-4 and IL-10. The levels ofbioactive IL-12 that can be released by triggering with an anti-CD40 mAb or with a T cell hybridoma are high (range 260-4700 pg/ml from 1 • 106 DC in 72 h). The CD40-mediated pathway indicates that IL-12 production is induced in DC upon interaction with activated, CD40 ligand-expressing helper T cells, even in the absence of cognate antigen recognition. Side-by-side comparison oflL-12 production, and blocking experiments employing an anti-CD40 ligand n'LAb, suggest that the CD40-mediated pathway is quantitatively more significant than induction via the MHC class II molecule. The importance of the CD40/CD40 ligand interaction for IL-12 induction in DC likely contributes to the recent finding that mice lacking the CD40 ligand are impaired in mounting Thl type cell-mediated immune responses.
I
L-12, a 70-kD heterodimeric cytokine composed of co-.valentty linked p35 and p40 chains has emerged as a central cytokine in the immune response (1) . IL-12 stimulates NK cells, mediates Thl development, and fosters CTL development. It can be produced by monocytes and macrophages in response to intracellular pathogens, bacteria (e.g., staphylococci) and bacterial products. Recent reports indicate that dendritic cells (DC) also release bioactive IL-12. One report described that anti-IL-12 blocks the capacity of murine DC to skew the response of naive transgenic T cells to the Thl phenotype (2) , and another shows induction of IL-12 p40/p35 mRNA in bone-marrow derived murine DC upon uptake ofmicroparticle-absorbed protein antigen (3) . Human epidermal Langerhans cells are also a source of IL-12 (4) . We have recently used several criteria for demonstration of IL-12 p40 and p35 mRNA as well as IL-12 p40 and bioactive p70 proteins, to show that murine and human DC release IL-12 upon conventional stimuli such as staphylococcus aureus (5) . We also found that DC produced bioactive IL-12 upon interaction with T cells without standard stir " ~-,~h as bacterial products. Here, we describe the regulation oflL-12 in DC. We show that ligation of CD40 and MHC class II molecules independently trigger IL-12 production by DC in large amounts, and that IL-12 release by DC is downregulated by IL-4 as well as by IL-10.
Materials and Methods
Mice. Specific pathogen-free C57BL/6, BALB/c, and C3H/ He mice of both sexes were purchased from Charles River (Sulzfeld, Germany) and used at 6 to 8 wk of age.
Media and Reagents for Cell Culture. Culture medium was IKPMI-1640 supplemented with 10% fetal calf serum, gentamycin, and 2-mercaptoethanol (Biological Industries, Kibbutz Beit Haemek, Israel). Dendritic Cells. A previously described standard procedure involving overnight culture and final purification by rosetting with Is-coated ox erythrocytes (EAIgG) was applied for the preparation of DC from spleen (6 Finally, sodium periodate-modified primary naive murine CD4+ T cells were used as a stimulus for DC in the oxidative mitogenesis assay. They were prepared from nylon wool non-adherent spleen and mesenteric lymph node cells by treatment with a cocktail of mAbs against MHC class II, B220, and CD8 plus complement. Periodation was performed as described (10) . Regulation of IL-12 production by DC was studied using recombinant murine IL-4 (specific activity 1 • 107 U/mg) and IL-10 (specific activity 5 • 10 s U/mg), both purchased from Genzyme Corporation (Cambridge, MA). Measurement ofIL-12. IL-12 was measured in 0-36 and 0-72 h supernatants of DC cultures (1 • 106 D C / 1 ml/24 well) + stimulation with the mAbs or cytokines mentioned above. Likewise, supernatants were analyzed after 36 and 72 h of coculture with periodate-modified T cells or T-T hybridomas. Murine IL-12 p70 heterodimer was detected by a two-site enzyme-linked immunosorbent assay (ELISA) (11) using rat anti-mouse IL-12 mAbs that were generously provided by Drs. M.K. Gately and D.H. Presky (Hoffmann-La Roche, Nutley, NJ). 9A5 (anti-IL-12 p75) was used as capture antibody, 5C3 (anti-IL-12 p40) as detection antibody (11) . Detection limit was about 20 pg/ml of IL-12. IL-12 was also measured indirectly via determination o f l N F y produced by Thl type T cell blasts as described (5) .
Detection of lL-12 mRNA by In Situ Hybridization. This was done essentially as described (5) using a non-radioactive labeling system (Boehringer Mannheim, Mannheim, Germany). For detection of bound digoxigenin-labeled probes we used FITC-conjugated sheep anti-digoxigenin antibodies (Boehringer Mannheim).
Detection of lL-12 mRNA by quantitative PCR and liquid hybridization.
For the quantitative PCR. the PCR Mimic Construction Kit TM (No. 1700-1; Invitrogen, Leek, The Netherlands) was used to produce a neutral DNA fragment spanning 548 bp, flanked by the IL-12 primers used for the PCR. For quantitation, IL-12 p40 PCR. was performed under standard conditions using the same amount of template cDNA with serial dilutions of mimic DNA (10-0,001 attomol/t*l in tenfold dilutions or in some cases twofold dilutions spanning the concentration range of interest). The template DNA was quantitated by comparison of the brightness of ethidium bromide stained bands of amplified p40 versus minic DNA. Wincam TM software was employed for evaluation. The primers for murine IL-12 p40 were designed according to published sequences (12) and spanned one intron (bp 
Results and Discussion

Dendritic Cells Produce IL-12 upon Interaction with T Cells.
W h e n purified murine spleen D C sensitized naive helper T cells in an oxidative mitogenesis assay we found that substantial amounts (up to almost 5 ng/ml from 106 DC) of bioactive p70 heterodimer were released, yet only after 72 h. This was detected by a p70-specific ELISA (Table I , rows A vs. B) as well as by I F N y induction in a bioassay (data not shown). In addition, we observed a strong upregulation o f l L -1 2 p40 mI<NA by in situ hybridization (Fig. 1) . Our earlier data strongly suggested (5) that in these experiments the source o f l L -1 2 is the DC.
The delayed onset o f IL-12 production suggested that a molecule that is upregulated by T cells upon activation and could interact with a receptor on D C might be responsible for triggering IL-12 production in DC. A prime candidate was the CD40 ligand (CD40-L) as (a) CD40-L is expressed following T cell activation (13) and we confirmed this by flow cytometry (Fig. 2, A and B) , (b) CD40-L is known to interact with the CD40 molecule on mature, immunostimulatory DC, and to induce several biological effects (e.g., upregulation o f M H C class I and II, adhesion and costimulatory molecules) (14) , and (c) CD40-L has been shown to induce release oflL-12, albeit at lower levels (~< 100 pg/ml) from human (15) and murine (15a) monocytes. Addition o f blocking anti-CD40-L mAb greatly reduced IL-12 production (Table 1 , rows B vs. C) as well as p40 IL-12 mR.NA expression (not shown) by D C upon antigen-specific activation of resting T cells, indicating that the CD40-L/CD40 interaction is indeed a major trigger for production oflL-12.
W e next studied IL-12 production upon interaction of D C with peptide-specific, M H C class II-restricted T cell 
. Expression ofCD40 hgand on T cells. Periodated CD4+ T cells freshly isolated (A) or after 48 h of coculture with dendritic cells (B)
and T cell hybridoma 1H3.1 (C and D) were analyzed by fluorescence flow cytometry using mAb anti-gp39. Large cells (i.e., activated T cell blasts) were selected by forward scatter/side scatter gating in B. CD40 ligand (arrowed curve in each panel) appears on primary T cells in rehybridomas as a model for activated T cells. We noted that even an antigen-nonspecific interaction (i.e., no peptide or control peptide added) with T cell hybridomas induced high levels of IL-12 (Table 1 , rows F vs. G and K). Production of IL-12 was, however, still higher in the presence of the appropriate peptide enabhng antigen-specific activation of the T cell hybridomas (Table 1 , rows G vs./). Using anti-CD40-L mAb, we found that the T cell hybridomas increased their constitutive CD40-L expression further, as expected, upon activation (Fig. 2, C and D) . Anti-CD40-L prevented most of the IL-12 production, that occurred upon mixing DC with T-T hybrid cells. However, blocking was incomplete notably in the case of the antigen-specific interaction (Table 1, 
744
Regulation of Dendritic Cell-derived IL-12 (Table 2 ). These findings supported the conclusion drawn from the experiments using DC and T cell hybridomas (including the T cell hybridoma 1H3.1 that recognizes the very same Eci 52-68 + I-A 6 complex [8] , see above and Table 1 ) that ligation of MHC class II molecules directly signals IL-12 production in DC, independent of the indirect effect of CD40-L upregulation on T cells via TCP,-mediated activation (13) . Quantitative P,T-PCP, and non-radioactive in situ hybridization demonstrated that the induction of IL-12 production via CD40 and MHC class II molecules is transcriptionally regulated (Tables 1 and 2, Fig. 3 ). In situ analyses showed furthermore that IL-12 mRNA is induced in virtually all DC and is not restricted to subsets.
IL-4 and IL-10 Downregulate IL-12 Production by Dendritic
Cells. Downregulation oflL-12 production by DC might be biologically relevant with regard to Thl skewing of the immune response (1) and tolerance (16) . We therefore tested the effect oflL-4 and IL-10 which both can suppress IL-12 production by mononuclear phagocytes (17, 18) . IL-10 as well as IL-4 were also able to suppress T cell-induced as well as anti-CD40 mAb-triggered IL-12 production in DC (Table 3) . In a pilot experiment DC were stimulated for 24 h with anti-CD40 mAb in the presence of IL-4 or IL-10 followed by thorough washing and continued culture for another 56 h in the absence of IL-4 or IL-10. Induction of IL-12 was much lower (272 and 90 pg/ml, respectively) as compared with control cultures that had been without cytokines and/or without anti-CD40 during the first 24 h (885 and >1000 pg/ml, respectively). This suggests that the inhibitory effects of IL-4 and IL-10 are not fully irreversible. Downregulation of IL-12 production in DC as well as other antigen presenting cells (17, 18) explains why both IL-10 and IL-4 suppress Thl development (19) . Downregulation of IL-12 production by IL-10 may also contribute to development of hapten-specific tolerance (20) as the induction of contact hypersensitivity critically depends on DC-derived IL-12 (16) . It appears also that IL-4 drives Th2 development so potently as it does not only directly act on precursor T cells (19) but in addition also downregulates IL-12 production in antigen-presenting cells including DC.
Possible Biological Relevance of T Cell-induced IL-12 Production by Dendritic Cells.
It is evident that antigen-presenting cells including DC release IL-12 upon antigen-specific interaction with T cells, and can thus skew the immune response to Thl including IFN~ production from resulting Thl cells (2, 5) . We have shown here that ligation by T cells of MHC class II as well as CD40 molecules independently triggers high levels oflL-12 production in DC. Relative to macrophages and B cells, DC can make larger amounts of IL-12. The induction of IL-12 production via the CD40 molecule readily explains our finding that helper T cells, upon activation and expression of CD40-L, can induce IL-12 production even in the absence of cognate antigen recognition by T cells. By making so much IL-12 upon contact with T cells, either via MHC class II or CD40, the DC would skew these T cells towards a Thl phenotype (5) and thus promote strong cell mediated immunity.
